The ABPI is at the heart of a health sector-wide effort to establish consensus on key Brexit issues including medicines regulation, UK and EU trading relationships, access to talent, and the future of UK science.
We are creating a new relationship with the European Union that secures patient access to medicines and protects public health.
A voluntary agreement between the Government and the pharmaceutical industry.
We work with the government, industry, medical charities and organisations and trade associations to support the pharmaceutical and life sciences sector.
Celebrating the history of the UK pharmaceutical industry in changing the lives of patients, and the people involved in its past, present and future
18 January 2018
As the new AMR Industry Alliance launches its first progress report, ABPI chief executive Mike Thompson welcome the industry’s willingness to work collaboratively to detect, prevent and control AMR.
16 January 2018
As the MHRA publishes an update to pharmaceutical companies on preparing for Brexit, the ABPI reaffirms the importance of patient and public health in negotiations.